|
Mar 11
|
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
|
|
Mar 9
|
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
|
|
Mar 8
|
Here’s Why Artisan Mid Cap Fund Harvested BioNTech SE (BNTX)
|
|
Mar 7
|
BioNTech Announces Planned Retirement of Sean Marett
|
|
Mar 6
|
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
|
|
Mar 5
|
Here’s Why BioNTech SE (BNTX) Declined 12.2% in Q4
|
|
Mar 4
|
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
|
|
Mar 4
|
It’s Time! 3 Dodgy Pharma Stocks to Sell in February
|
|
Jan 17
|
Time To Worry? Analysts Are Downgrading Their BioNTech SE (NASDAQ:BNTX) Outlook
|
|
Jan 9
|
UPDATE 2-BioNTech predicts return to revenue growth in 2025
|
|
Jan 9
|
Midday movers: Boeing, CrowdStrike and more
|
|
Jan 9
|
BioNTech predicts return to revenue growth in 2025
|
|
Jan 9
|
BioNTech expects 2024 revenues of about $3.3 bln
|
|
Jan 9
|
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 24
|
15 Undervalued Defensive Stocks For 2024
|
|
Dec 21
|
BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer
|
|
Dec 19
|
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
|
|
Dec 19
|
UPDATE 2-German court quashes CureVac patent after challenge by BioNTech
|
|
Dec 18
|
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
|
|
Dec 18
|
BioNTech aims to start mRNA vaccine output in Rwanda in 2025
|